跳至主要内容
临床试验/CTRI/2021/11/038338
CTRI/2021/11/038338招募中未知

Prospective, Multinational, observational registry utilizing a cloud-based eCRF accessible to investigators. This registry will be open to all physicians managing T2DM, HF or CKD across the world

AstraZeneca Pharma India Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. ââ?°Â¥18 years old
  • 2. Having type 2 diabetes, CKD and/or HF
  • 3. Providing written informed consent to participate in the study

排除标准

  • 1. Having any life-threatening co-morbidity and a life expectancy of less than 1 year
  • 2. Participating in any interventional trial requiring informed consent

研究者

相似试验